These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3594510)

  • 1. Compensated cardiogenic shock: a subset with damage limited to liver and kidneys. The possible salutary effect of low-dose dopamine.
    Naschitz JE; Yeshurun D
    Cardiology; 1987; 74(3):212-8. PubMed ID: 3594510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiogenic hepatorenal syndrome.
    Naschitz JE; Yeshurun D; Shahar J
    Angiology; 1990 Nov; 41(11):893-900. PubMed ID: 2244692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute heart failure: acute cardiogenic pulmonary edema and cardiogenic shock].
    Sánchez Marteles M; Urrutia A
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():14-9. PubMed ID: 24930078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopamine in patients with cardiogenic shock (author's transl)].
    Kikis D; Esser H; Trübestein G
    Med Klin; 1977 Jul; 72(28-29):1212-7. PubMed ID: 329088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First experiences with the use of dopamine (hydroxytyramine) in cardiogenic shock].
    Döring D; Fleischmann HJ; Heunisch K; Köhler H; Trenckmann H
    Z Gesamte Inn Med; 1971 Dec; 26(24):759-63. PubMed ID: 5152441
    [No Abstract]   [Full Text] [Related]  

  • 6. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of dopamine in patients with cardiogenic shock.
    Holzer J; Karliner JS; O'Rourke RA; Pitt W; Ross J
    Am J Cardiol; 1973 Jul; 32(1):79-84. PubMed ID: 4713114
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term use of dopamine in shock in patients with massive thromboembolism of the pulmonary artery].
    Parkhomenko AN; Sirenko IuN
    Vrach Delo; 1989 Mar; (3):43-5. PubMed ID: 2750118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic study of dopamine used in chronic heart failures and in cardiogenic shock as a complication of acute myocardial infarct].
    Flammang D; Sebastien P; Bouvrain Y
    Ann Anesthesiol Fr; 1975 Dec; 16(9):669-72. PubMed ID: 5028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and therapeutic effects of intravenous dopamine.
    Théroux P; Mizgala HF; Bourassa MG
    Can Med Assoc J; 1977 Mar; 116(6):645-8. PubMed ID: 608165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of cardiogenic shock].
    Ritz R
    Schweiz Med Wochenschr; 1988 Apr; 118(17):626-9. PubMed ID: 2898169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination high dose amrinone and dopamine in the management of moribund cardiogenic shock after open heart surgery.
    Olsen KH; Kluger J; Fieldman A
    Chest; 1988 Sep; 94(3):503-6. PubMed ID: 3409728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catecholamines in internal medicine emergencies].
    Brandt D; Pristautz H; Klein W
    Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.
    Garber PJ; Mathieson AL; Ducas J; Patton JN; Geddes JS; Prewitt RM
    Can J Cardiol; 1995 Jan; 11(1):30-6. PubMed ID: 7850662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopamine in the treatment of coronary shock].
    Zimin IuV; Kuznetsova GV; Evdokimov VV
    Kardiologiia; 1979 May; 19(5):34-9. PubMed ID: 459209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiogenic shock.
    Rackley CE; Russell RO; Mantle JA; Rogers WJ
    Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A; Kübler A; Sliwinski M; Paszkowska A
    Anaesthesist; 1978 Apr; 27(4):183-6. PubMed ID: 655365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of dopamine in the treatment of shock states].
    Wattel F; Chopin C; Gosselin B; Durocher A; Vallet D; Stevigny R; Ramon P; Berzin B
    Anesth Analg (Paris); 1976; 33(3):355-74. PubMed ID: 1015658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.